Discover and read the best of Twitter Threads about #Novacyt
Most recents (24)
(2011) #Roche launched the LightCycler Nano POC 🔬
Via white label with IT-IS who also licensed to @NovacytGroup (sold as q32 + q16)
2014 IT-IS sought legal damages against Roche for patent infringement
2020 @NovacytGroup bought IT-IS
#Novacyt #ALNOV
Via white label with IT-IS who also licensed to @NovacytGroup (sold as q32 + q16)
2014 IT-IS sought legal damages against Roche for patent infringement
2020 @NovacytGroup bought IT-IS
#Novacyt #ALNOV
"Many research labs use 96-well instruments, but the average number of samples per run is often below the capacity of the instruments"
🤏 "should satisfy the needs of many PCR researchers by fitting well into their work environment"
Roche Marketing VP Fernandes-McAlear
#Novacyt
🤏 "should satisfy the needs of many PCR researchers by fitting well into their work environment"
Roche Marketing VP Fernandes-McAlear
#Novacyt
“The new LightCycler® Nano Instrument delivers proven high quality at an affordable price & expands our qPCR business into a new segment. Customers will love the smart design of the instrument & appreciate the high quality data they can produce with it.”
Gerd Haberhausen, Roche
Gerd Haberhausen, Roche
Listing plans (AIM, EuroNext, NASDAQ)
"As of today we have no plans to change our listings"
#Novacyt
"As of today we have no plans to change our listings"
#Novacyt
Fact check:
#Novacyt Exsig underwent Clinical & NHS validation
👇 Wrong:
"So in essence if you look you will not find a document (that I have ever seen) saying Exsig formally passed its in service trial in relation to the contract whereas you will find one for Promate"
#ALNOV
#Novacyt Exsig underwent Clinical & NHS validation
👇 Wrong:
"So in essence if you look you will not find a document (that I have ever seen) saying Exsig formally passed its in service trial in relation to the contract whereas you will find one for Promate"
#ALNOV
For supposed researched person, he's lazy. His thesis called out #Novacyt's 3rd party manufacturing for lowering margins
#ALNOV "invests in infrastructure to bring previously outsourced work in-house & to drive further automation, leading to improved margins & process controls"
#ALNOV "invests in infrastructure to bring previously outsourced work in-house & to drive further automation, leading to improved margins & process controls"
@UnrollHelper unroll
#ncyt #alnov #novacyt
That's nice. PROmate, as part of the national microbiology framework has it's own contract.
The £4m amount until next Year has been announced by @NovacytGroup a few weeks ago. But without any minimal amount secured as stated.
1/4
That's nice. PROmate, as part of the national microbiology framework has it's own contract.
The £4m amount until next Year has been announced by @NovacytGroup a few weeks ago. But without any minimal amount secured as stated.
1/4
#ncyt #alnov #novacyt
Now we have the contract in front of us.
"By execution of the contract, DHSC shall submit to the supplier a purchase order for the sum of xxxxx"
Interesting 🧐
2/4
Now we have the contract in front of us.
"By execution of the contract, DHSC shall submit to the supplier a purchase order for the sum of xxxxx"
Interesting 🧐
2/4
#ncyt #alnov #novacyt
Our relation with DHSC is far from over.
Monthly meetings to review several points.
Thanks to Steve Gibson, CFO, for signing this contract on behlaf of @NovacytGroup 🧐
3/4
Our relation with DHSC is far from over.
Monthly meetings to review several points.
Thanks to Steve Gibson, CFO, for signing this contract on behlaf of @NovacytGroup 🧐
3/4
2020 Figure's:
🇬🇧 70% sales NHS/DHSC
👨💼 18% via Distributors (UK & International)
🔬 12% Private Lab sales
#Novacyt #ALNOV #NCYT
🇬🇧 70% sales NHS/DHSC
👨💼 18% via Distributors (UK & International)
🔬 12% Private Lab sales
#Novacyt #ALNOV #NCYT
#Novacyt's COVID-19 tests received UKAS Medical Accreditation for use within 4 UK private labs in past month
✅ The Scientists Laboratory Ltd (10k daily capacity)
✅ Epistem Ltd
✅ MDNA Life Sciences Ltd
Courtesy of @BlackbirdInvest
#ALNOV #NCYT
✅ The Scientists Laboratory Ltd (10k daily capacity)
✅ Epistem Ltd
✅ MDNA Life Sciences Ltd
Courtesy of @BlackbirdInvest
#ALNOV #NCYT
Wren Healthcare received UKAS Accreditation for use of #Novacyt's Point of Care solution
Q16/32's with ProMATE, no bio hazard safety cabinet required
At least 9 Versalabs have been supplied with approx 900 daily capacity each #ALNOV #NCYT
Thank you @Larry64450205
Q16/32's with ProMATE, no bio hazard safety cabinet required
At least 9 Versalabs have been supplied with approx 900 daily capacity each #ALNOV #NCYT
Thank you @Larry64450205
MDNA & Newcastle airport 👇
While we await Q&A answers from & AGM agenda next week from @NovacytGroup here are some of the slides & video
Diagnostics set to boom 💥
#novacyt #ALNOV #NCYT building blocks in place for sustained growth
Diagnostics set to boom 💥
#novacyt #ALNOV #NCYT building blocks in place for sustained growth
#ncyt #alnov #novacyt
A little mixed thread.
Our R&D, the bioinformatic reports, SNPsig, PROmate, Versalab, DHSC, takeovers, the RNSs, wierd stuff, whats next, some risks, etc
1/20
A little mixed thread.
Our R&D, the bioinformatic reports, SNPsig, PROmate, Versalab, DHSC, takeovers, the RNSs, wierd stuff, whats next, some risks, etc
1/20
Waiting for AF LFT.
1m tests/week to start.
Shouldnt be long to wait, as theyre already looking for tenders for it. (See UN notice of interest)
For home use and professionnals. Very important. It opens many markets !
2/n
1m tests/week to start.
Shouldnt be long to wait, as theyre already looking for tenders for it. (See UN notice of interest)
For home use and professionnals. Very important. It opens many markets !
2/n
Why os the AG LFT not far away :
3/n
3/n
#Novacyt more than COVID-19 🔬
🔎 550 non COVID range
. Human pathogen
. Veterinary
. Food, water & agriculture
. Bio threats
. Genotyping
Find out in April how #NCYT will leveraging it's role within 🇬🇧 diagnostics infrastructure
#ALNOV #Primerdesign
🔎 550 non COVID range
. Human pathogen
. Veterinary
. Food, water & agriculture
. Bio threats
. Genotyping
Find out in April how #NCYT will leveraging it's role within 🇬🇧 diagnostics infrastructure
#ALNOV #Primerdesign
#Novacyt's Genesig tests are designed to run on the q16 & larger q32 which is one of the fastest qPCR instruments in the world
I'm looking forward to seeing ProMATE being adapted to further simplify #NCYT testing base
I'm looking forward to seeing ProMATE being adapted to further simplify #NCYT testing base
#Novacyt have a Massive range of Respiratory Infection detection kits
& as demonstrated by COVID they are fast to react to new threats
& now UK has the tools & political will to test
#Novacyt #ALNOV #NCYT #Primerdesign
& as demonstrated by COVID they are fast to react to new threats
& now UK has the tools & political will to test
#Novacyt #ALNOV #NCYT #Primerdesign
Some PCR investor stress caused by reissue of LFT Tender
It's value was cut by 2/3rd's
£8b down from £20b
Bids submitted by 7th April
Add on bid evaluation period
& 30 days contact standstill / freeze period
#Novacyt #Microgen compete for both
bidstats.uk/tenders/2020/W…
It's value was cut by 2/3rd's
£8b down from £20b
Bids submitted by 7th April
Add on bid evaluation period
& 30 days contact standstill / freeze period
#Novacyt #Microgen compete for both
bidstats.uk/tenders/2020/W…
Is #Novacyt taking off 🛫?
BCG analyzed 🔬 🇺🇸, 🇫🇷 , 🇩🇪 , 🇮🇹, 🇪🇸 Outlook
Testing's likely to follow similar trajectories
Peak COVID demand occurring in the seasonally affected first quarters of 2021 & 2022
#Novacyt #ALNOV #NCYT
bcg.com/en-in/publicat…
Testing's likely to follow similar trajectories
Peak COVID demand occurring in the seasonally affected first quarters of 2021 & 2022
#Novacyt #ALNOV #NCYT
bcg.com/en-in/publicat…
Don't you wonder sometimes
About genes and vision?
#Novacyt #ALNOV #NCYT
“Our SNPsig assays are the same high level of accuracy as our PCR SARS-CoV-2 portfolio,” Mullis said. More variants will be added as they are identified.
About genes and vision?
#Novacyt #ALNOV #NCYT
“Our SNPsig assays are the same high level of accuracy as our PCR SARS-CoV-2 portfolio,” Mullis said. More variants will be added as they are identified.
“primary challenge for COVID-19 diagnostics companies is ensuring their products continue to accurately test for the virus, regardless of the variant, and to innovate at the challenging pace required to remain clinically relevant"
Graham Mullis #Novacyt
bioworld.com/articles/50347…
Graham Mullis #Novacyt
bioworld.com/articles/50347…
Prof Sharon Peacock Cambridge Uni, her work sequencing variants may be required for at least 10 yrs
bbc.co.uk/news/uk-560199…
#Novacyt #ALNOV #NCYT
bbc.co.uk/news/uk-560199…
#Novacyt #ALNOV #NCYT
When the ship sways you don't jump into waters where sharks lurk #LFT's
Jump out of a plane during turbulence
Not me 😎 plane sailing
Jump out of a plane during turbulence
Not me 😎 plane sailing
#SureScreen #LFT💩
"now in their final stage of validation in clinical trials" NOT APPROVED
"sensitivity against high viral loads" 💩🔬
#MattHancock Daily Briefing (08/02/21) test detects 1/3 cases
gov.uk/government/new…
Who's life would you risk?
#Novacyt #PCR 🔬🏅☑️
"now in their final stage of validation in clinical trials" NOT APPROVED
"sensitivity against high viral loads" 💩🔬
#MattHancock Daily Briefing (08/02/21) test detects 1/3 cases
gov.uk/government/new…
Who's life would you risk?
#Novacyt #PCR 🔬🏅☑️
COVID Antigen LFT validation prioritisation criteria update (8/02/21)
SureScreen were awarded direct tender on 8th. Could struggle to diagnose asymptomatics, test only detects "High viral loads"?
@GoodLawProject @JolyonMaugham @Independent
gov.uk/guidance/later…
SureScreen were awarded direct tender on 8th. Could struggle to diagnose asymptomatics, test only detects "High viral loads"?
@GoodLawProject @JolyonMaugham @Independent
gov.uk/guidance/later…
UK micro > small cap 🔬 snap shot
#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m
#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene
Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m
#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m
#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene
Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m
There's a margin of error to account for BBI accounts which aren't public, awaiting GeneDrive which reports 31/03, Avacta account were published 23/01 last yr.
Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
#ncyt #alnov #novacyt
SP Angel published a New note on #ncyt
You Can Access the full document here :
novacyt.com/wp-content/upl…
The target Price is 1433p, but there are many interesting things in this document.
Thread ⤵️
1/15
SP Angel published a New note on #ncyt
You Can Access the full document here :
novacyt.com/wp-content/upl…
The target Price is 1433p, but there are many interesting things in this document.
Thread ⤵️
1/15
First, the FY2020 results are better than in the last forecast.
Actual vs previous forecast
Revenue 311m vs 287m
Cash 101m vs 79m
The cash accumulated will allow them to develop themselves into a "high margin clinical diagnostics" sector.
2/n
Actual vs previous forecast
Revenue 311m vs 287m
Cash 101m vs 79m
The cash accumulated will allow them to develop themselves into a "high margin clinical diagnostics" sector.
2/n
Revenues and forecast.
Things are really important here.
We Can see the revenues decrease until 2023 on this forecast.
But look at the cash accumulation. This will not sit in the bank and wait !
So, when they use this cash for aquisitions for ex.,
3/n
Things are really important here.
We Can see the revenues decrease until 2023 on this forecast.
But look at the cash accumulation. This will not sit in the bank and wait !
So, when they use this cash for aquisitions for ex.,
3/n
#ncyt #alnov
#novacyt has a great capacity in identifying the needs of the market.
Many tests developped this year respond to precise needs
And there are many more to Come this year
- History
- promate & its future
- rt-lamp
- LFT
- sequencing and variants
Thread 1/17 ⤵️
#novacyt has a great capacity in identifying the needs of the market.
Many tests developped this year respond to precise needs
And there are many more to Come this year
- History
- promate & its future
- rt-lamp
- LFT
- sequencing and variants
Thread 1/17 ⤵️
Little History.
- covid-HT was specificly developped for the AZN lighthouse lab in Cambridge
- Winterplex was one of the first of his kind, developped to answer the needs of NHS
2/n
- covid-HT was specificly developped for the AZN lighthouse lab in Cambridge
- Winterplex was one of the first of his kind, developped to answer the needs of NHS
2/n
- exsig direct direct to symplify the workflow of the PCR
- mink strain test : theyre the first ones, again, for this test, who could have had a sognificant importance if this strain had spread
3/n
- mink strain test : theyre the first ones, again, for this test, who could have had a sognificant importance if this strain had spread
3/n
📹 is worth a thousand 🖋
ProMATE saving many pipettes steps 🧫
Better 🥳 (work flow)
Faster 🏃 (180 mins to 80)
Safer ☣ (no need for Class ii cabinet)
#Novacyt #ALNOV #NCYT
Taking it to the next phase
ProMATE saving many pipettes steps 🧫
Better 🥳 (work flow)
Faster 🏃 (180 mins to 80)
Safer ☣ (no need for Class ii cabinet)
#Novacyt #ALNOV #NCYT
Taking it to the next phase
It's simple, @PrimerdesignLtd designed it that way
Efficient workflow, further enabling Point of Care testing within NHS settings 👨🔬 & beyond 👩🏻🔬🗺️
Efficient workflow, further enabling Point of Care testing within NHS settings 👨🔬 & beyond 👩🏻🔬🗺️
World Economic Forum: Global Risks Report 2021
Each year world leaders meet to assess and vote on global risks for the years ahead. This year they met in the middle a pandemic.
#NCYT #ALNOV #NVYTF #NOVACYT
Each year world leaders meet to assess and vote on global risks for the years ahead. This year they met in the middle a pandemic.
#NCYT #ALNOV #NVYTF #NOVACYT
Leaders were asked to assess the *Likelihood* of risks, while also assessing the *Impact* of each global risk on a scale of 1 to 5.
1 representing a minimal impact and 5 a catastrophic impact.
1 representing a minimal impact and 5 a catastrophic impact.
They were also asked to consider the top 5 greatest risks over the next 10 years.
#ncyt #alnov
@BioGradLabs are using #novacyt's covid pcr test.
➡️Clinics in 6 cities.
➡️Large scale screening services (schools,work places,sport events,...)
➡️Processing up to 15k tests per day (lft+pcr+antibody)
➡️"most sensitive test for pre flight covid screening"
👇👇
@BioGradLabs are using #novacyt's covid pcr test.
➡️Clinics in 6 cities.
➡️Large scale screening services (schools,work places,sport events,...)
➡️Processing up to 15k tests per day (lft+pcr+antibody)
➡️"most sensitive test for pre flight covid screening"
👇👇
#ncyt #alnov #novacyt
In the pictures, see @BioGradLabs testing kits being prepared to be sent to partner schools.
Here, an article about @BioGradLabs, and the expected increase of covid tests After the New 5 days quarantine rules :
business-live.co.uk/economic-devel…
In the pictures, see @BioGradLabs testing kits being prepared to be sent to partner schools.
Here, an article about @BioGradLabs, and the expected increase of covid tests After the New 5 days quarantine rules :
business-live.co.uk/economic-devel…
#ncyt #alnov #novacyt
Thread:
Summary and vision of the rns "Advances in Research & Development"
- NPT
- Promate
- rt-lamp
- antigen test
- Danish strain test
- it-is production
- conclusion
1/8
Thread:
Summary and vision of the rns "Advances in Research & Development"
- NPT
- Promate
- rt-lamp
- antigen test
- Danish strain test
- it-is production
- conclusion
1/8
Npt:
More than convincing results on a large sample:
- S&S greater than 99%
- Quick results
- mid-nose sample
We can calmly assume:
➡️ a contract with nursing homes will arrive
➡️That the contract with the NHS will enter phase 2
2/8
More than convincing results on a large sample:
- S&S greater than 99%
- Quick results
- mid-nose sample
We can calmly assume:
➡️ a contract with nursing homes will arrive
➡️That the contract with the NHS will enter phase 2
2/8
Promate and NPT:
New reagents:
- simplified use
- less reagents needed and lyophilized
- reduction of the duration of a test
- viral inactivation: less protection needed
➡️ Facilitate the use of Qs in small hospitals and nursing homes
➡️ New Contracts
3/8
New reagents:
- simplified use
- less reagents needed and lyophilized
- reduction of the duration of a test
- viral inactivation: less protection needed
➡️ Facilitate the use of Qs in small hospitals and nursing homes
➡️ New Contracts
3/8
#ncyt #alnov #novacyt
Fil :
Récapitulatif et vision de la rns "Avancées en Recherche & Développement"
- NPT
- Promate
- rt-lamp
- test antigénique
- test souche danoise
- production it-is
- conclusion
1/8
Fil :
Récapitulatif et vision de la rns "Avancées en Recherche & Développement"
- NPT
- Promate
- rt-lamp
- test antigénique
- test souche danoise
- production it-is
- conclusion
1/8
Npt :
Résultats plus que probants sur un large echantillon :
- S&S supérieurs à 99%
- Résultats rapides
- prélèvement mi-nez
On peut sereinement supposer :
➡️qu'un contrat avec les maisons de soins va arriver
➡️Que le contrat avec le NHS va entrer en phase 2
2/8
Résultats plus que probants sur un large echantillon :
- S&S supérieurs à 99%
- Résultats rapides
- prélèvement mi-nez
On peut sereinement supposer :
➡️qu'un contrat avec les maisons de soins va arriver
➡️Que le contrat avec le NHS va entrer en phase 2
2/8
Promate et NPT :
Nouveau réactifs :
- utilisation simplifiée
- moins de réactifs nécessaires et lyophilisés
- réduction de la durée d'un test
- inactivation virale : moins de protections nécessaires
➡️ Faciliter l'utilisation des Qs dans les petits hôpitaux et ehpads
3/8
Nouveau réactifs :
- utilisation simplifiée
- moins de réactifs nécessaires et lyophilisés
- réduction de la durée d'un test
- inactivation virale : moins de protections nécessaires
➡️ Faciliter l'utilisation des Qs dans les petits hôpitaux et ehpads
3/8
#ncyt #alnov #novacyt
A tous ceux qui croient que les tests sont finis, que ncyt retourne a la cave, que cette entreprise ne vaut rien, que le covid, c'est le passé, que les vaccins arrivent
Réveillez vous
Les vaccins ne sont pas prêts
Les tests dureront
Ncyt innove sans cesse
A tous ceux qui croient que les tests sont finis, que ncyt retourne a la cave, que cette entreprise ne vaut rien, que le covid, c'est le passé, que les vaccins arrivent
Réveillez vous
Les vaccins ne sont pas prêts
Les tests dureront
Ncyt innove sans cesse
#novacyt #alnov #ncyt
Fil : vaccins et tests, la fin des valeurs covid ?
Certains essaient de faire croire que le covid est derrière nous, que les vaccins sont prêts et que demain tout rentre dans l'ordre.
1/10
Fil : vaccins et tests, la fin des valeurs covid ?
Certains essaient de faire croire que le covid est derrière nous, que les vaccins sont prêts et que demain tout rentre dans l'ordre.
1/10
Les études en cours sont plus que précoces, sur de petirséchantillons, avec de nouvelles technologies jamais testées, et sans recul !
Bien évidemment, si un vaccin sûr venait à anéantir cette pandémie, j'en serait plus qu'heureux. Mais ce n'est pas encore le cas, et de loin
2/10
Bien évidemment, si un vaccin sûr venait à anéantir cette pandémie, j'en serait plus qu'heureux. Mais ce n'est pas encore le cas, et de loin
2/10
#ncyt #alnov #novacyt
R&D update :
- NPT going forward
- Promate rollout for better NPT efficiency
- developing Rt-lamp
- developing LFT
- developing New covid test for a New strain
R&D update :
- NPT going forward
- Promate rollout for better NPT efficiency
- developing Rt-lamp
- developing LFT
- developing New covid test for a New strain
